Distribution and levels of cell surface expression of CD33 and CD123 in acute myeloid leukemia

Owing to the more recent positive results with the anti-CD33 immunotoxin gemtuzumab ozogamicin, therapy against acute myeloid leukemias (AMLs) targeting CD33 holds many promises. Here, CD33 and CD123 expression on AML blasts was studied by flow cytometry in a cohort of 319 patients with detailed inf...

Descripción completa

Detalles Bibliográficos
Autores principales: Ehninger, A, Kramer, M, Röllig, C, Thiede, C, Bornhäuser, M, von Bonin, M, Wermke, M, Feldmann, A, Bachmann, M, Ehninger, G, Oelschlägel, U
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4080210/
https://www.ncbi.nlm.nih.gov/pubmed/24927407
http://dx.doi.org/10.1038/bcj.2014.39

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4080210/
https://www.ncbi.nlm.nih.gov/pubmed/24927407
http://dx.doi.org/10.1038/bcj.2014.39

Ejemplares similares